glutathione patch lifewave LiveWave Y-Age Patches LifeWave Y-Age Glutathione Patches |

Read the evidence A 2017 meta-analysis (N = 1,211) found that in patients with hyperuricaemia and CKD, urate-lowering treatment slowed renal function decline, limited proteinuria and reduced the relative risk of cardiovascular events or renal failure by over 50% 12 A 2020 meta-analysis (N = 6,458) found that urate-lowering treatment did not significantly reduce the risk of major adverse cardiovascular events, kidney failure or all-cause mortality

Clinical trials ran for 12 weeks without safety concerns

The repair findings span both acute injury models and surgically induced defect models, suggesting the response is not specific to a single class of tissue insult

In men, HCG can encourage the creation of sperm